D. E. Shaw & Co., Inc. - GENMARK DIAGNOSTICS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$22,244,000
+48.5%
930,726
-9.3%
0.02%
+61.5%
Q4 2020$14,983,000
+3.8%
1,026,220
+0.9%
0.01%
-13.3%
Q3 2020$14,439,000
-22.1%
1,016,832
-19.3%
0.02%
-31.8%
Q2 2020$18,529,000
+2665.5%
1,259,623
+673.9%
0.02%
+2100.0%
Q1 2020$670,000
-78.1%
162,762
-74.5%
0.00%
-75.0%
Q4 2019$3,064,000
+32.1%
637,159
+66.5%
0.00%
+33.3%
Q3 2019$2,320,000
+28.9%
382,726
+38.0%
0.00%
+50.0%
Q2 2019$1,800,000
-29.9%
277,353
-23.4%
0.00%
-33.3%
Q1 2019$2,568,000
+49.7%
362,148
+2.6%
0.00%
+50.0%
Q4 2018$1,716,000
-31.9%
352,964
+2.9%
0.00%
-33.3%
Q3 2018$2,521,000
+73.0%
343,019
+50.2%
0.00%
+50.0%
Q2 2018$1,457,000
+268.9%
228,326
+214.6%
0.00%
+100.0%
Q1 2018$395,000
+320.2%
72,584
+221.5%
0.00%
Q4 2017$94,000
-89.5%
22,575
-75.7%
0.00%
-100.0%
Q3 2017$896,000
-70.2%
93,079
-63.4%
0.00%
-80.0%
Q2 2017$3,010,000
+22.0%
254,382
+32.1%
0.01%
+25.0%
Q1 2017$2,468,000
+1874.4%
192,541
+1784.5%
0.00%
Q4 2016$125,000
-39.6%
10,217
-61.8%
0.00%
Q4 2015$207,000
+140.7%
26,719
+143.2%
0.00%
Q3 2015$86,000
-74.2%
10,988
-70.1%
0.00%
Q2 2015$333,000
-36.2%
36,719
-8.8%
0.00%
-100.0%
Q1 2015$522,000
+234.6%
40,242
+251.0%
0.00%
Q4 2014$156,000
-51.4%
11,464
-68.0%
0.00%
Q3 2014$321,000
-73.7%
35,774
-69.7%
0.00%
-100.0%
Q2 2013$1,222,000118,2260.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders